Re-engineered honey has proved to be a novel and successful development for Matoke Pharma, as well as a crucial step on the UK biotech company’s plans to target antimicrobial resistance (AMR).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback